论文部分内容阅读
目的分析美托洛尔结合稳心颗粒对高血压心脏病室性早搏治疗的临床价值。方法筛选本院80例高血压心脏病室性早搏者参与本次试验,依据随机抽签法将其分组,即观察组、常规组各40例分别给予美托洛尔与稳心颗粒、美托洛尔治疗,对比两组患者的临床总有效率、不良反应发生率。结果观察组的总有效率(92.5%)明显优于参照组(75.0%),P<0.05;两组不良反应发生率较接近,P>0.05。结论对高血压心脏病室性早搏者采取美托洛尔与稳心颗粒治疗,可获得显效疗效,且安全性较高,具有借鉴意义。
Objective To analyze the clinical value of Metoprolol combined with Wenxin Granule in the treatment of ventricular premature beats of hypertensive heart disease. Methods Screening 80 cases of hypertensive heart disease in our hospital premature ventricular contractions were involved in this test, according to random lottery method to group, the observation group, the conventional group of 40 patients were given Metoprolol and Wenxin particles, Metoprolol Treatment, the two groups of patients compared the total effective rate of the clinical, the incidence of adverse reactions. Results The total effective rate (92.5%) in the observation group was significantly better than that in the reference group (75.0%), P <0.05. The incidence of adverse reactions in both groups was close (P> 0.05). Conclusion Metoprolol and Wenxin Granule can be used to treat patients with premature ventricular hypertrophy in hypertensive patients with heart disease, and the curative effect can be obtained with high safety.